Efficacy and Safety of Intra-articular Sacroiliac Glucocorticoid Injections in Ankylosing Spondylitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nam, Bora | - |
dc.contributor.author | Kim, Tae-Hwan | - |
dc.contributor.author | Lee, Sung Won | - |
dc.contributor.author | Kim, Hyunah | - |
dc.contributor.author | Kim, Yun Jin | - |
dc.contributor.author | Jun, Jae-Bum | - |
dc.contributor.author | Lee, Seunghun | - |
dc.date.accessioned | 2022-01-21T04:40:03Z | - |
dc.date.available | 2022-01-21T04:40:03Z | - |
dc.date.issued | 2022-01 | - |
dc.identifier.issn | 1076-1608 | - |
dc.identifier.issn | 1536-7355 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/20225 | - |
dc.description.abstract | Background/Aims To assess the efficacy and safety of intra-articular sacroiliac glucocorticoid injection in ankylosing spondylitis (AS). Methods Patients with AS undergoing fluoroscopy-guided intra-articular sacroiliac glucocorticoid injection were enrolled between 2012 and 2018. Efficacy was assessed by numeric pain rating scale, acute phase reactants, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index, and Ankylosing Spondylitis Disease Activity Score (ASDAS). Patients who started biologics within 3 months despite the intervention were compared with those not starting biologics, hence: the nonbiologic group. Results A total of 96 patients were treated, with a total of 107 injections. After intervention, there were significant decreases in numeric pain rating scale (7.8 +/- 1.8 vs. 3.3 +/- 2.2, p < 0.001) and acute phase reactants level (erythrocyte sedimentation rate [ESR] 23.0 mm/h [10.0-47.0 mm/h] vs. 13.0 mm/h [4.0-27.0 mm/h], p < 0.001; C-reactive protein [CRP] 1.0 mg/dL [0.2-2.7 mg/dL] vs. 0.2 mg/dL [0.2-0.9 mg/dL], p < 0.001). Disease activity scores also decreased for BASDAI (6.2 +/- 1.8 vs. 4.5 +/- 2.5, p = 0.001), Bath Ankylosing Spondylitis Functional Index (5.5 [4.1-7.0] vs. 1.8 [0.5-4.1], p = 0.001), ASDAS-CRP (2.9 +/- 1.0 vs. 2.3 +/- 1.3, p = 0.046), and ASDAS-ESR (3.7 +/- 1.1 vs. 2.4 +/- 1.3, p < 0.001). However, 12 patients (12.5%) started biologics within 3 months. These patients showed higher ESR (91.0 mm/h [IQR 21.0-113.0 mm/h] vs. 21.5 mm/h [IQR 9.5-43.0 mm/h], p = 0.010), CRP (8.0 mg/dL [IQR 1.11-17.1 mg/dL] vs. 0.8 mg/dL [IQR 0.2-1.8 mg/dL], p = 0.002), BASDAI (7.4 +/- 1.2 vs. 5.9 +/- 1.8, p = 0.027), and ASDAS-CRP (4.0 +/- 0.5 vs. 2.8 +/- 1.0, p = 0.004) than the nonbiologic group. There was no serious adverse event. Conclusions Intra-articular sacroiliac glucocorticoid injection can be a safe and effective treatment option for active sacroiliitis in AS. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | Efficacy and Safety of Intra-articular Sacroiliac Glucocorticoid Injections in Ankylosing Spondylitis | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1097/RHU.0000000000001584 | - |
dc.identifier.wosid | 000733569200012 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Rheumatology, v.28, no.1, pp E26 - E32 | - |
dc.citation.title | Journal of Clinical Rheumatology | - |
dc.citation.volume | 28 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | E26 | - |
dc.citation.endPage | E32 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Rheumatology | - |
dc.relation.journalWebOfScienceCategory | Rheumatology | - |
dc.subject.keywordPlus | GUIDED CORTICOSTEROID INJECTION | - |
dc.subject.keywordPlus | RHEUMATOID-ARTHRITIS PATIENTS | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | COMPUTED-TOMOGRAPHY | - |
dc.subject.keywordPlus | STEROID INJECTION | - |
dc.subject.keywordPlus | JOINT | - |
dc.subject.keywordPlus | SPONDYLOARTHROPATHY | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | KNEE | - |
dc.subject.keywordAuthor | ankylosing spondylitis | - |
dc.subject.keywordAuthor | glucocorticoid injection | - |
dc.subject.keywordAuthor | intra-articular injection | - |
dc.subject.keywordAuthor | sacroiliitis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.